These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 4890296

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of tranexamic acid (AMCA) in menorrhagia with intrauterine contraceptive devices.
    Weström L, Bengtsson LP.
    J Reprod Med; 1970 Oct; 5(4):154-61. PubMed ID: 4940818
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of menorrhagia with tranexamic acid. A double-blind trial.
    Callender ST, Warner GT, Cope E.
    Br Med J; 1970 Oct 24; 4(5729):214-6. PubMed ID: 4919554
    [Abstract] [Full Text] [Related]

  • 4. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
    Bengtsson LP, Weström L.
    Lakartidningen; 1971 Aug 11; 68(33):3685-91. PubMed ID: 5129410
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [A new antifibrinolytic agent (cyclokapron) with effect against menorrhagia].
    Tidsskr Nor Laegeforen; 1969 Sep 15; 89(18):1437. PubMed ID: 5376311
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.
    Kouides PA, Byams VR, Philipp CS, Stein SF, Heit JA, Lukes AS, Skerrette NI, Dowling NF, Evatt BL, Miller CH, Owens S, Kulkarni R.
    Br J Haematol; 2009 Apr 15; 145(2):212-20. PubMed ID: 19236375
    [Abstract] [Full Text] [Related]

  • 13. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid.
    Lakhani KP, Marsh MS, Purcell W, Hardiman P.
    Ultrasound Obstet Gynecol; 1998 Apr 15; 11(4):283-5. PubMed ID: 9618854
    [Abstract] [Full Text] [Related]

  • 14. [Role of fibrinolysis in excessive menstrual bleeding].
    Bar-Am A, Toaf FR, Hertzberg M.
    Harefuah; 1976 Feb 15; 90(4):162-4. PubMed ID: 1269998
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.
    Kriplani A, Kulshrestha V, Agarwal N, Diwakar S.
    J Obstet Gynaecol; 2006 Oct 15; 26(7):673-8. PubMed ID: 17071438
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of hypermenorrhea with tranexamic acid].
    Petersen K, Jelert H, Diernaes E, Detlefsen GU.
    Ugeskr Laeger; 1983 Sep 05; 145(36):2759-60. PubMed ID: 6356545
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.